Support Thyroid Cancer Research
Since 1975, the number of people diagnosed with thyroid cancer has tripled. It is now the ninth most common cancer in the United States.
Although most patients survive thyroid cancer, the treatment can bring with it significant stress, work interruption, increased medical costs and, in some cases, long-lasting side effects related to treatment.
Additionally, thyroid cancer has a genetic component -- meaning it is often seen in families. As a result, those who are considered high-risk for thyroid cancer can benefit from specialty care and opportunities for clinical trial enrollment.
To combat the growing instances of thyroid cancer, to provide better patient care and to help those people who are at high-risk for thyroid cancer, the University of Michigan created ThyCARE (Thyroid Cancer Research).ThyCARE would not exist without the generous support from the Wigginton family through the Punya Thyroid Cancer Research Foundation.
For more information, or to make a donation by mail, please contact Maher Salah:
Office of Medical Development
Attention: Maher Salah
1000 Oakbrook Drive, Suite 100
Ann Arbor, MI 48104